Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Three small uncontrolled human publications cover fewer than 30 subjects total and use no standardized pharmaceutical preparation
A shorter, cleaner formula in protective packaging is usually the safer bet for a sensitive, oxidation-prone ingredient like GHK-Cu
A typical course is 46 weeks, followed by reassessment
What The FDA Category 1 vs Category 2 Status Means Today Under the FDAs interim bulk substances framework for 503A compounding pharmacies: Category 1: Bulk Drug Substances under evaluation with sufficient supporting safety information
There is no confirmed FDA approval timeline as of 2026
US$ 26.01
US$ 26.69
US$ 21.98
US$ 22.06
US$ 21.37
US$ 24.84
US$ 26.98
US$ 22.77
US$ 24.96
